- Advertisement -

Insilico Medicine develops highly selective FGFR2/3 dual inhibitor for cancer treatment

Fibroblast growth factor receptors (FGFRs) are critical drivers of oncogenesis in various solid tumors, including urothelial carcinoma, hepatocellular carcinoma, ovarian cancer and lung adenocarcinoma....

NIH establishes a unified clinical trial network for testing COVID-19 vaccines

Reviewed by Emily Henderson, B.Sc.Jul 8 2020 The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has...

Euclid space mission releases first scientific results and new images of the cosmos

European space mission Euclid has released early scientific papers based on observations made by the space telescope, along with five new astronomical images of...

Toxic Aggregates Shunted from Neurons to Microglia via Nanotubes

A clearance mechanism involving microglia has been known to relieve neurons of toxic protein aggregates such as those associated with Alzheimer’s disease and Parkinson’s...

A Virtual Insight into Cell Culture Using Advanced Analytics

Broadcast Date: March 29, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW Integrating digital tools into research and process development can help...

Nerve Pathway Discovery May Lead to New Therapies for Mental Disorders

Researchers in Japan have identified a nerve pathway in mice involved in the processing of rewarding and distressing stimuli and situations. The pathway, originating in...

China Sets Framework for Advanced Therapeutic Development

China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell...

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners...

NEW YORK CITY — Patients, colleagues and peers gathered in midtown Manhattan last week to celebrate Carl June, MD, and Michel Sadelain, MD, PhD,...

China Sets Framework for Advanced Therapeutic Development

China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell...

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and...

NEW YORK CITY — Patients, colleagues and peers gathered in midtown Manhattan last week to celebrate Carl June, MD, and Michel Sadelain, MD, PhD,...

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million...

more new items

China Sets Framework for Advanced Therapeutic Development

China’s Order 818—Regulations on the Administration of Clinical Research and Clinical Translation and Application of Biomedical New Technologies—establishes a new commercialization pathway for cell...

Perseverance, Persistence Key to CAR T Success, Say Ross Prize Winners...

NEW YORK CITY — Patients, colleagues and peers gathered in midtown Manhattan last week to celebrate Carl June, MD, and Michel Sadelain, MD, PhD,...

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone...

Merck & Co. will partner with Protillion Biosciences to discover multiple new therapy candidates through a collaboration that could generate up to $510 million...